Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 39

Sort by

Sort Order Select

Journal Articles

Development of a Novel Class of Agents Targeting the RNA-Splicing Machinery in Myeloid Malignancies

Blood (2018) 132 (Supplement 1): 211.

https://doi.org/10.1182/blood-2018-99-116411

Published: 2018

Journal Articles

Activated Factor IX As a Candidate for the Initial Protease in the Coagulation Cascade

Tina M Misenheimer, PhD, Kraig T Kumfer, MD PhD, Barbara E Bates, MS, Brad S Schwartz, MD

Blood (2017) 130 (Supplement 1): 235.

https://doi.org/10.1182/blood.V130.Suppl_1.235.235

Published: 2017

Journal Articles

Synthetic Partially Reduced Human Neutrophil Peptide (HNP)-1 Inhibits Platelet Adhesion and Aggregation on Von Willebrand Factor-Collagen Surfaces Under Arterial Shear Stress through a Disulfide Bond Reduction Mechanism

Jenny K. McDaniel, MD, Khalil Bdeir, PhD, Douglas B. Cines, MD, X. Long Zheng, MD, PhD

Blood (2016) 128 (22): 3722.

https://doi.org/10.1182/blood.V128.22.3722.3722

Published: 2016

Journal Articles

Human Neutrophil Peptides (HNPs) Enhance Thrombus Formation Under Flow By Inhibiting Proteolytic Activity of Plasma ADAMTS13 Metalloprotease

Vikram G. Pillai, PhD, Jialing Bao, PhD, Jenny McDaniel, MD, Catherine B. Zander1, PhD, Wenjing Cao, MD, PhD, Khalil Bdeir, PhD, Douglas B. Cines, MD, X. Long Zheng, MD PhD

Blood (2015) 126 (23): 105.

https://doi.org/10.1182/blood.V126.23.105.105

Published: 2015

Journal Articles

Assembly of Prothrombinase on Endothelial Cells: Receptor-Mediated or Phospholipid-Driven?

Mikhail Galkin, PhD, Harlan Bradford, BA, Sriram Krishnaswamy, PhD

Blood (2015) 126 (23): 2267.

https://doi.org/10.1182/blood.V126.23.2267.2267

Published: 2015

Journal Articles

Establishing Modified Human CYP4B1 As a Novel Suicide Gene System for Adoptive T-Cell Therapies

Katharina Roellecke, M.Sc., Constanze Wiek, PhD, Christof Kramm, MD, Allan Rettie, PhD, Helmut Hanenberg, MD

Blood (2015) 126 (23): 5550.

https://doi.org/10.1182/blood.V126.23.5550.5550

Published: 2015

Journal Articles

A Multi-Center Phase 1b, Open-Label, Dose-Finding Pilot Study to Evaluate the Combination of Carfilzomib and Cyclophosphamide with Dexamethasone (CCyD) Prior to Autologous Stem Cell Transplant (ASCT) in Patients with Transplant Eligible Newly Diagnosed Multiple Myeloma

William I. Bensinger, MD, Robert Vescio, MD, Cristina Gasparetto, MD, Elber S. Camacho, MD, Rajneesh Nath, MD, Christina L. Gomes, MD, David D. Smith, PhD, Jatin J. Shah, Brian G. M. Durie, MD

Blood (2014) 124 (21): 4739.

https://doi.org/10.1182/blood.V124.21.4739.4739

Published: 2014

Journal Articles

Inhibition of Wnt Signaling By Dimethyl Fumarate Results in in Vitro and in Vivo Clearance of Chronic Lymphocytic Leukemia Cells and Has Additive Activity with Ibrutinib

Christina C.N. Wu, PhD, Fitzgerald Lao, Hongying Li, PhD, Laura Rassenti, PhD, Thomas J. Kipps, MD, Karen Messer, PhD, Dennis A. Carson, MD, Michael Y. Choi, MD

Blood (2014) 124 (21): 4683.

https://doi.org/10.1182/blood.V124.21.4683.4683

Published: 2014

Journal Articles

Platelet Apoptosis in Adult Immune Thrombocytopenia. Relationship with Auto-Antibodies, Platelet Function and Treatment

Geraldine Contrufo, Ana C Glembotsky, Nora P Goette, Paola R Lev, Matías Grodzielski, Marta S Pierdominici, Dardo Alberto Riveros, MD, Verónica S Montero, Alejandro García, Felisa C. Molinas, MD PhD, Paula G. Heller, MD, Rosana F Marta

Blood (2014) 124 (21): 2792.

https://doi.org/10.1182/blood.V124.21.2792.2792

Published: 2014

Journal Articles

Acylcarnitines Are Novel Anticoagulant Lipids That Target Factor Xa and That Are Reduced in Plasma of Venous Thrombosis Patients Based on Untargeted and Targeted Metabolomics

Hiroshi Deguchi, MD PhD, Yajnavalka Banerjee, PhD, Gary Siuzdak, PhD, Sunia Trauger, PhD, Ewa Kalisiak, PhD, Jose A. Fernandez, MD PhD, Linh Hoang, Minerva Tran, Subramanian Yegneswaran, PhD, Darlene J Elias, MD, John H. Griffin, PhD

Blood (2014) 124 (21): 2797.

https://doi.org/10.1182/blood.V124.21.2797.2797

Published: 2014

Journal Articles

Enhanced Fibrinolysis by Proteolysed Coagulation Factor Xa Is Inhibited by Rivaroxaban

Rolinda R.L. Carter, Kimberley Talbot, Tyler W Smith, MD, Agnes Y.Y. Lee, MD, MSc, FRCPC, Edward L.G. Pryzdial

Blood (2012) 120 (21): 3352.

https://doi.org/10.1182/blood.V120.21.3352.3352

Published: 2012

Journal Articles

Antibody ESH4, Against the Factor VIII C2 Domain, Causes a Remote Change near the Factor IXa Active Site and Inhibition That Is Related to Membrane Composition

Valerie A Novakovic, M.S., Junhong Lu, Ph.D., Gary E. Gilbert, M.D.

Blood (2012) 120 (21): 3355.

https://doi.org/10.1182/blood.V120.21.3355.3355

Published: 2012

Journal Articles

Conformational Dynamics of Prothrombin Dictate Its Ordered Cleavage by Prothrombinase

Michelle Homsher, PhD, Erin Zekas, BS, Sriram Krishnaswamy, Ph.D.

Blood (2012) 120 (21): 3359.

https://doi.org/10.1182/blood.V120.21.3359.3359

Published: 2012

Journal Articles

Selective Inhibition of Activated B-Cell Lymphoma Cells by a Novel Small Molecule Inhibitor of NF-κB

John T, Norton, PhD, Tomoko Hayashi, M.D., Ph.D., Raymond P. Wu, Ph.D., Howard Cottam, PhD, Dennis A. Carson, M.D.

Blood (2011) 118 (21): 2498.

https://doi.org/10.1182/blood.V118.21.2498.2498

Published: 2011

Journal Articles

The Effect of Factor IXa on Thrombin Generation Activity Determination: rFIXFc Vs. BeneFIX ®

Yang Buyue, PhD, Ekta Seth Chhabra, PhD, Li Wang, Jurg M Sommer, PhD

Blood (2011) 118 (21): 2266.

https://doi.org/10.1182/blood.V118.21.2266.2266

Published: 2011

Journal Articles

Rapid Anuric Acute Kidney Injury After the Administration of IV Anti-D in a Teenager

L. Kristy Haggett, D.O., Kanyalakshmi Ayyanar, MD, Larry Shoemaker, M.D.

Blood (2011) 118 (21): 4691.

https://doi.org/10.1182/blood.V118.21.4691.4691

Published: 2011

Journal Articles

Protein S Regulates Factor IXa/VIIIa Activity Independent of Activated Protein C

Rinku Majumder, PhD

Blood (2010) 116 (21): 2196.

https://doi.org/10.1182/blood.V116.21.2196.2196

Published: 2010

Journal Articles

Imaging of Coagulation Reactions During Thrombus Formation In Vivo with Novel Fluorescent Protein Derivatives

Lacramioara Ivanciu, PhD, Rodney M. Camire, PhD, Sriram Krishnaswamy, PhD

Blood (2010) 116 (21): 817.

https://doi.org/10.1182/blood.V116.21.817.817

Published: 2010

Journal Articles

Comparison of Cytotoxic Mechanisms of Anti-CD20 Antibodies GA101 and Rituximab Against Fresh Chronic Lymphocytic Leukemia Cells

Lina Reslan, PhD, Stéphane Dalle, Cindy Tournebize, AE, Stephanie Herveau, Emeline Cros, AE, Charles Dumontet

Blood (2010) 116 (21): 2467.

https://doi.org/10.1182/blood.V116.21.2467.2467

Published: 2010

Journal Articles

LACK of IRON Binding by Pixantrone IS ASSOCIATED with Reduced PRODUCTION of Reactive Oxygen SPECIES and Myoctye Cytotoxicity IN VITRO.

Miles Hacker, Ph.D., Marc McKennon, Ph.D., Jack W. Singer, MD

Blood (2009) 114 (22): 4806.

https://doi.org/10.1182/blood.V114.22.4806.4806

Published: 2009

NARROW

Development of a Novel Class of Agents Targeting the RNA-Splicing Machinery in Myeloid Malignancies

Activated Factor IX As a Candidate for the Initial Protease in the Coagulation Cascade

Synthetic Partially Reduced Human Neutrophil Peptide (HNP)-1 Inhibits Platelet Adhesion and Aggregation on Von Willebrand Factor-Collagen Surfaces Under Arterial Shear Stress through a Disulfide Bond Reduction Mechanism

Human Neutrophil Peptides (HNPs) Enhance Thrombus Formation Under Flow By Inhibiting Proteolytic Activity of Plasma ADAMTS13 Metalloprotease

Assembly of Prothrombinase on Endothelial Cells: Receptor-Mediated or Phospholipid-Driven?

Establishing Modified Human CYP4B1 As a Novel Suicide Gene System for Adoptive T-Cell Therapies

A Multi-Center Phase 1b, Open-Label, Dose-Finding Pilot Study to Evaluate the Combination of Carfilzomib and Cyclophosphamide with Dexamethasone (CCyD) Prior to Autologous Stem Cell Transplant (ASCT) in Patients with Transplant Eligible Newly Diagnosed Multiple Myeloma

Inhibition of Wnt Signaling By Dimethyl Fumarate Results in in Vitro and in Vivo Clearance of Chronic Lymphocytic Leukemia Cells and Has Additive Activity with Ibrutinib

Platelet Apoptosis in Adult Immune Thrombocytopenia. Relationship with Auto-Antibodies, Platelet Function and Treatment

Acylcarnitines Are Novel Anticoagulant Lipids That Target Factor Xa and That Are Reduced in Plasma of Venous Thrombosis Patients Based on Untargeted and Targeted Metabolomics

Enhanced Fibrinolysis by Proteolysed Coagulation Factor Xa Is Inhibited by Rivaroxaban

Antibody ESH4, Against the Factor VIII C2 Domain, Causes a Remote Change near the Factor IXa Active Site and Inhibition That Is Related to Membrane Composition

Conformational Dynamics of Prothrombin Dictate Its Ordered Cleavage by Prothrombinase

Selective Inhibition of Activated B-Cell Lymphoma Cells by a Novel Small Molecule Inhibitor of NF-κB

The Effect of Factor IXa on Thrombin Generation Activity Determination: rFIXFc Vs. BeneFIX ®

Rapid Anuric Acute Kidney Injury After the Administration of IV Anti-D in a Teenager

Protein S Regulates Factor IXa/VIIIa Activity Independent of Activated Protein C

Imaging of Coagulation Reactions During Thrombus Formation In Vivo with Novel Fluorescent Protein Derivatives

Comparison of Cytotoxic Mechanisms of Anti-CD20 Antibodies GA101 and Rituximab Against Fresh Chronic Lymphocytic Leukemia Cells

LACK of IRON Binding by Pixantrone IS ASSOCIATED with Reduced PRODUCTION of Reactive Oxygen SPECIES and Myoctye Cytotoxicity IN VITRO.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only